Acrivastine
CLINICAL USE
Antihistamine:
DOSE IN NORMAL RENAL FUNCTION
8 mg 3 times a day
PHARMACOKINETICS
348.4
50
60
0.6–0.7
1.5/–
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
8 mg 1–2 times a day
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
Unknown dialysability. Dose as in
GFR <10 mL/min
Unknown dialysability. Dose as in
GFR <10 mL/min
Unknown dialysability. Dose as in
GFR <10 mL/min
Unknown dialysability. Dose as in
GFR 10 to 20 mL/min
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
effects
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
Manufacturers do not recommend use in
patients with significant renal impairment